Table 1.
Baseline characteristics
| Characteristics | Value (n = 49) |
|---|---|
| Mean age, years | 45.0 ± 14.0 |
| Male sex (%) | 45 (91.8) |
| Family history of CVD (%) | 20 (40.8) |
| Angina (%) | 3 (6.1) |
| Diabetes (%) | 2 (4.1) |
| Hypertension (%) | 12 (24.5) |
| Smoking (%) | 19 (38.8) |
| BMI > 30 (%) | 3 (6.1) |
| Drug abuse (%) | 2 (4.1) |
| Recent infection | |
| Respiratory tract (%) | 14 (28.6) |
| Flu-like symptoms (%) | 10 (20.4) |
| Other (%) | 3 (6.1) |
| Electrocardiographic changes | |
| Anterior ST-elevation (%) | 23 (46.9) |
| Anterior and inferior ST-elevation (%) | 24 (49.0) |
| T-inversion (%) | 6 (12.2) |
| Mean anterior ST-elevation, mm | 6.3 ± 3.7 |
| Mean inferior ST-elevation, mm | 1.8 ± 2.5 |
| Biomarkers | |
| CK-MB (mg/1) | 22.5 ± 45.8 |
| Troponin-T (μg/1) | 0.48 ± 0.87 |
| proBNP (pmol/1) | 106.5 ± 272.9 |
| CRP (mg/1) | 53.4 ± 77.5 |
| Echocardiography (n = 43) | |
| Mean EF (%) | 57.5 ± 7.5% |
| EF < 50%, n (%) | 5 (11.6%) |
| Medication on admission | |
| ACE-1/AT-II blocker, n (%) | 7 (14.3) |
| Beta-blocker, n (%) | 5 (10.2) |
| Statins, n (%) | 9 (18.4) |
| None, n (%) | 28 (57.1) |